Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Nexalin Technology develops non-invasive neurostimulation devices targeting mental health conditions such as anxiety, insomnia, depression, and PTSD. Utilizing proprietary waveform technology, the company offers cranial electrotherapy stimulation (CES) devices for clinical and home use. Its business includes device development, clinical trials, regulatory approval, and a virtual clinic platform to deliver cost-effective, drug-free treatments monitored by healthcare providers worldwide.
This description was generated via AI from an annual report. Updated about 1 year ago.